Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,204
archived clinical trials in
Healthy Studies

A Study to Examine the Distribution of PF-06372865 in the Brain of Healthy Volunteers Using Positron Emission Tomography and a Radioactive Tracer Following Oral Administration of One Dose of PF-06372865
A Phase 1, Open-Label Study To Evaluate Central Occupancy Of The Benzodiazepine Binding Site Of Gaba-A Receptors By Positron Emission Tomography (Pet) With Ligand [11c]Flumazenil Following Single Dose Of PF-06372865 In Healthy Subjects
Status: Enrolling
Updated:  8/15/2014
Pfizer Investigational Site
536
mi
from 43215
New Haven, CT
A Study to Examine the Distribution of PF-06372865 in the Brain of Healthy Volunteers Using Positron Emission Tomography and a Radioactive Tracer Following Oral Administration of One Dose of PF-06372865
A Phase 1, Open-Label Study To Evaluate Central Occupancy Of The Benzodiazepine Binding Site Of Gaba-A Receptors By Positron Emission Tomography (Pet) With Ligand [11c]Flumazenil Following Single Dose Of PF-06372865 In Healthy Subjects
Status: Enrolling
Updated: 8/15/2014
Pfizer Investigational Site
536
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
A Study of the Abuse Liability Potential of Samidorphan in Healthy, Non-Dependent, Recreational Opioid Users
A Randomized, Double-Blind, Placebo- and Positive-Controlled, Crossover Study to Evaluate the Abuse Potential and Safety of Orally Administered Samidorphan in Non-Dependent Recreational Opioid Users
Status: Enrolling
Updated:  8/15/2014
Alkermes Study Site
624
mi
from 43215
Overland Park, KA
A Study of the Abuse Liability Potential of Samidorphan in Healthy, Non-Dependent, Recreational Opioid Users
A Randomized, Double-Blind, Placebo- and Positive-Controlled, Crossover Study to Evaluate the Abuse Potential and Safety of Orally Administered Samidorphan in Non-Dependent Recreational Opioid Users
Status: Enrolling
Updated: 8/15/2014
Alkermes Study Site
624
mi
from 43215
Overland Park, KA
Click here to add this to my saved trials
Study to Assess Adhesion Quality and Wear of Placebo JNJ-35685-AAA-G-023 Transdermal System in Healthy Adults
Evaluation of Scoring Methods to Assess Adhesion Quality and Wear of the Placebo JNJ-35685-AAA-G-023 5.5 cm^2 and 44 cm^2 Transdermal Systems
Status: Enrolling
Updated:  8/19/2014
Clinical Research Facility
1967
mi
from 43215
Cypress, CA
Study to Assess Adhesion Quality and Wear of Placebo JNJ-35685-AAA-G-023 Transdermal System in Healthy Adults
Evaluation of Scoring Methods to Assess Adhesion Quality and Wear of the Placebo JNJ-35685-AAA-G-023 5.5 cm^2 and 44 cm^2 Transdermal Systems
Status: Enrolling
Updated: 8/19/2014
Clinical Research Facility
1967
mi
from 43215
Cypress, CA
Click here to add this to my saved trials
An Ascending Single-Dose Study of the Safety, Tolerability and Bioeffect of REGN1193
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
910
mi
from 43215
Dallas, TX
An Ascending Single-Dose Study of the Safety, Tolerability and Bioeffect of REGN1193
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
910
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Study to Determine the Safety, Tolerability, Pharmacokinetics, Food Effect and Pharmacodynamics of Single and Multiple Ascending Doses of P7435 in Healthy, Overweight or Obese Subjects
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Determine the Safety, Tolerability, Pharmacokinetics, Food Effect and Pharmacodynamics of Single and Multiple Ascending Doses of P7435 in Healthy, Overweight or Obese Subjects.
Status: Enrolling
Updated:  8/21/2014
Facility: Profil® Institute for Clinical Research, Inc.
1948
mi
from 43215
Chula Vista, CA
Study to Determine the Safety, Tolerability, Pharmacokinetics, Food Effect and Pharmacodynamics of Single and Multiple Ascending Doses of P7435 in Healthy, Overweight or Obese Subjects
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Determine the Safety, Tolerability, Pharmacokinetics, Food Effect and Pharmacodynamics of Single and Multiple Ascending Doses of P7435 in Healthy, Overweight or Obese Subjects.
Status: Enrolling
Updated: 8/21/2014
Facility: Profil® Institute for Clinical Research, Inc.
1948
mi
from 43215
Chula Vista, CA
Click here to add this to my saved trials
A Comparative Evaluation of the Performance and Fit of Pediatric Face Masks
A Comparative Evaluation of the Performance and Fit of Pediatric Face Masks
Status: Enrolling
Updated:  8/21/2014
Medline Industries, Inc
302
mi
from 43215
Mundelein, IL
A Comparative Evaluation of the Performance and Fit of Pediatric Face Masks
A Comparative Evaluation of the Performance and Fit of Pediatric Face Masks
Status: Enrolling
Updated: 8/21/2014
Medline Industries, Inc
302
mi
from 43215
Mundelein, IL
Click here to add this to my saved trials
Minimally Invasive Biomarker for Asthma Disease Severity
Feasibility of Using an Eosinophil-Specific Biomarker-(Eosinophil Peroxidase) in Clinical Practice
Status: Enrolling
Updated:  8/22/2014
Mayo Clinic Arizona
1645
mi
from 43215
Scottsdale, AZ
Minimally Invasive Biomarker for Asthma Disease Severity
Feasibility of Using an Eosinophil-Specific Biomarker-(Eosinophil Peroxidase) in Clinical Practice
Status: Enrolling
Updated: 8/22/2014
Mayo Clinic Arizona
1645
mi
from 43215
Scottsdale, AZ
Click here to add this to my saved trials
Skin Safety Study to Evaluate the Irritation Potential in Healthy Volunteers
A Phase 1, 21-Day, Randomized, Evaluator Blinded, Controlled Study to Evaluate the Irritation Potential of M518101 in Healthy Volunteers, Using a Cumulative Irritant Patch Test Design
Status: Enrolling
Updated:  8/25/2014
TKL research
472
mi
from 43215
Fair Lawn, NJ
Skin Safety Study to Evaluate the Irritation Potential in Healthy Volunteers
A Phase 1, 21-Day, Randomized, Evaluator Blinded, Controlled Study to Evaluate the Irritation Potential of M518101 in Healthy Volunteers, Using a Cumulative Irritant Patch Test Design
Status: Enrolling
Updated: 8/25/2014
TKL research
472
mi
from 43215
Fair Lawn, NJ
Click here to add this to my saved trials
Phase 1 Single Ascending Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of KBP-5074
An Open-Label, Parallel-Group, Single Ascending Dose Study in Healthy Subjects to Evaluate the Safety, Tolerability and Pharmacokinetics of KBP-5074 Following Oral Administration and With a Food Effect Panel
Status: Enrolling
Updated:  8/27/2014
Frontage Laboratories Inc.
391
mi
from 43215
Exton, PA
Phase 1 Single Ascending Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of KBP-5074
An Open-Label, Parallel-Group, Single Ascending Dose Study in Healthy Subjects to Evaluate the Safety, Tolerability and Pharmacokinetics of KBP-5074 Following Oral Administration and With a Food Effect Panel
Status: Enrolling
Updated: 8/27/2014
Frontage Laboratories Inc.
391
mi
from 43215
Exton, PA
Click here to add this to my saved trials
Bioavailability Study of 3 Tablet Formulations vs. Capsule Formulation of JNJ-56021927 in Fasting Healthy Male Participants
A Single-Dose, Open-Label, Randomized, Parallel-Group Study to Assess the Relative Bioavailability of 3 Tablet Formulations of JNJ-56021927 With Respect to the Capsule Formulation of JNJ-56021927 Under Fasted Conditions in Healthy Male Subjects
Status: Enrolling
Updated:  9/5/2014
Clinical Research Facility
1658
mi
from 43215
Tempe, AZ
Bioavailability Study of 3 Tablet Formulations vs. Capsule Formulation of JNJ-56021927 in Fasting Healthy Male Participants
A Single-Dose, Open-Label, Randomized, Parallel-Group Study to Assess the Relative Bioavailability of 3 Tablet Formulations of JNJ-56021927 With Respect to the Capsule Formulation of JNJ-56021927 Under Fasted Conditions in Healthy Male Subjects
Status: Enrolling
Updated: 9/5/2014
Clinical Research Facility
1658
mi
from 43215
Tempe, AZ
Click here to add this to my saved trials
Comparing the Effect of Whey and Soy Protein on the Absorption of Pomegranate Polyphenols in the Human Body
Dietary Protein in Pomegranate Ellagitannin Bioavailability
Status: Enrolling
Updated:  9/23/2014
UCLA Center for Human Nutrition
1982
mi
from 43215
Los Angeles, CA
Comparing the Effect of Whey and Soy Protein on the Absorption of Pomegranate Polyphenols in the Human Body
Dietary Protein in Pomegranate Ellagitannin Bioavailability
Status: Enrolling
Updated: 9/23/2014
UCLA Center for Human Nutrition
1982
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Study to Assess Drug-Drug Interaction Between Itraconazole or Gemfibrozil and JNJ-56021927
An Open-Label, Randomized, Parallel-Group Drug-Drug Interaction Study to Assess the Effect of Multiple Doses of Itraconazole or Gemfibrozil on the Pharmacokinetics of a Single Dose of JNJ-56021927 in Healthy Male Subjects
Status: Enrolling
Updated:  9/25/2014
Clinical Research Facility
1658
mi
from 43215
Tempe, AZ
Study to Assess Drug-Drug Interaction Between Itraconazole or Gemfibrozil and JNJ-56021927
An Open-Label, Randomized, Parallel-Group Drug-Drug Interaction Study to Assess the Effect of Multiple Doses of Itraconazole or Gemfibrozil on the Pharmacokinetics of a Single Dose of JNJ-56021927 in Healthy Male Subjects
Status: Enrolling
Updated: 9/25/2014
Clinical Research Facility
1658
mi
from 43215
Tempe, AZ
Click here to add this to my saved trials
Pre-Workout on Exercise Performance and Cognition
A Randomized, Double-Blind, Crossover Clinical Trial Comparing the Effects of Four Pre-Workout Beverages on Muscular Strength and Endurance and Cognitive Performance in Healthy Adult Males
Status: Enrolling
Updated:  9/29/2014
Miami Research Associates
994
mi
from 43215
Miami, FL
Pre-Workout on Exercise Performance and Cognition
A Randomized, Double-Blind, Crossover Clinical Trial Comparing the Effects of Four Pre-Workout Beverages on Muscular Strength and Endurance and Cognitive Performance in Healthy Adult Males
Status: Enrolling
Updated: 9/29/2014
Miami Research Associates
994
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Efficacy, Safety and Tolerability Study of Agile AG200-15 Transdermal Contraceptive Delivery System
A Single-arm, Open-label, Multicenter Phase 3 Study of the Contraceptive Efficacy, Safety and Tolerability of the AG200-15 Transdermal Contraceptive Delivery System (TCDS)
Status: Enrolling
Updated:  10/2/2014
Seattle Women's
2005
mi
from 43215
Seattle, WA
Efficacy, Safety and Tolerability Study of Agile AG200-15 Transdermal Contraceptive Delivery System
A Single-arm, Open-label, Multicenter Phase 3 Study of the Contraceptive Efficacy, Safety and Tolerability of the AG200-15 Transdermal Contraceptive Delivery System (TCDS)
Status: Enrolling
Updated: 10/2/2014
Seattle Women's
2005
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Bioequivalence Study Comparing Naltrexone SR/Bupropion SR Trilayer Tablets From Two Manufacturers
A Phase 1 Bioequivalence Study of Naltrexone SR/Bupropion SR Combination Trilayer Tablets From Two Manufacturers in Healthy Subjects
Status: Enrolling
Updated:  10/3/2014
Quintiles Phase One Services
623
mi
from 43215
Overland Park, KA
Bioequivalence Study Comparing Naltrexone SR/Bupropion SR Trilayer Tablets From Two Manufacturers
A Phase 1 Bioequivalence Study of Naltrexone SR/Bupropion SR Combination Trilayer Tablets From Two Manufacturers in Healthy Subjects
Status: Enrolling
Updated: 10/3/2014
Quintiles Phase One Services
623
mi
from 43215
Overland Park, KA
Click here to add this to my saved trials
A Study to Evaluate the Effects of JNJ-54861911 on Electrocardiogram Intervals in Healthy Particiants
A Randomized, Double-blind, Placebo- and Positive-controlled, Multiple-dose, Four-way, Cross-over Study to Evaluate the Effects of Repeated Oral Doses of JNJ-54861911 on Electrocardiogram Intervals in Healthy Subjects
Status: Enrolling
Updated:  10/7/2014
Clinical Research Facility
1658
mi
from 43215
Tempe, AZ
A Study to Evaluate the Effects of JNJ-54861911 on Electrocardiogram Intervals in Healthy Particiants
A Randomized, Double-blind, Placebo- and Positive-controlled, Multiple-dose, Four-way, Cross-over Study to Evaluate the Effects of Repeated Oral Doses of JNJ-54861911 on Electrocardiogram Intervals in Healthy Subjects
Status: Enrolling
Updated: 10/7/2014
Clinical Research Facility
1658
mi
from 43215
Tempe, AZ
Click here to add this to my saved trials
Sensor Off Study Using a Nellcor USB Pulse Oximetry Monitor Interface Cable
Sensor Off Study Using a Nellcor USB Pulse Oximetry Monitor Interface Cable
Status: Enrolling
Updated:  10/10/2014
Boulder Clinical Laboratory
1171
mi
from 43215
Boulder, CO
Sensor Off Study Using a Nellcor USB Pulse Oximetry Monitor Interface Cable
Sensor Off Study Using a Nellcor USB Pulse Oximetry Monitor Interface Cable
Status: Enrolling
Updated: 10/10/2014
Boulder Clinical Laboratory
1171
mi
from 43215
Boulder, CO
Click here to add this to my saved trials
MAD Study Evaluating the Safety, Tolerability, and PK Effects of N91115 in Healthy Subjects
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple-Ascending Dose Study Evaluating the Safety, Tolerability, and Pharmacokinetic Effects of N91115 in Healthy Subjects
Status: Enrolling
Updated:  10/14/2014
DaVita Clinical Research
1167
mi
from 43215
Lakewood, CO
MAD Study Evaluating the Safety, Tolerability, and PK Effects of N91115 in Healthy Subjects
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple-Ascending Dose Study Evaluating the Safety, Tolerability, and Pharmacokinetic Effects of N91115 in Healthy Subjects
Status: Enrolling
Updated: 10/14/2014
DaVita Clinical Research
1167
mi
from 43215
Lakewood, CO
Click here to add this to my saved trials
Bioequivalence Study of Metformin Component of Canagliflozin and Metformin Fixed Dose Combination Immediate Release (IR) Tablet Comparing With Metformin IR Tablet Co-administered With Canagliflozin Tablet in Healthy Fed and Fasted Participants
A Single-Dose, Open-Label, Randomized, 4-Way Crossover Pivotal Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Immediate Release (IR) 1 x (50 mg/500 mg) With Respect to the Metformin IR Tablet (Locally Sourced From Canada [Glucophage, 1 x 500 mg]) Coadministered With Canagliflozin (1 x 50 mg) in Healthy Fed and Fasted Subjects
Status: Enrolling
Updated:  10/20/2014
Clinical Research Facility
721
mi
from 43215
Lincoln, NE
Bioequivalence Study of Metformin Component of Canagliflozin and Metformin Fixed Dose Combination Immediate Release (IR) Tablet Comparing With Metformin IR Tablet Co-administered With Canagliflozin Tablet in Healthy Fed and Fasted Participants
A Single-Dose, Open-Label, Randomized, 4-Way Crossover Pivotal Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Immediate Release (IR) 1 x (50 mg/500 mg) With Respect to the Metformin IR Tablet (Locally Sourced From Canada [Glucophage, 1 x 500 mg]) Coadministered With Canagliflozin (1 x 50 mg) in Healthy Fed and Fasted Subjects
Status: Enrolling
Updated: 10/20/2014
Clinical Research Facility
721
mi
from 43215
Lincoln, NE
Click here to add this to my saved trials
A Single Oral Dose Study Of PF-06427878 In Healthy Adult Subjects
A Phase 1, Randomized, Double-blind, Placebo-controlled Study To Assess The Safety, Tolerability, And Pharmacokinetics Of Single Escalating Oral Doses Of Pf-06427878 Co-administered With Meal In Healthy Adult Subjects
Status: Enrolling
Updated:  10/22/2014
New Haven Clinical Research Unit
537
mi
from 43215
New Haven, CT
A Single Oral Dose Study Of PF-06427878 In Healthy Adult Subjects
A Phase 1, Randomized, Double-blind, Placebo-controlled Study To Assess The Safety, Tolerability, And Pharmacokinetics Of Single Escalating Oral Doses Of Pf-06427878 Co-administered With Meal In Healthy Adult Subjects
Status: Enrolling
Updated: 10/22/2014
New Haven Clinical Research Unit
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
A Study In Healthy People To Evaluate Safety, Toleration, Pharmacokinetics And Pharmacodynamics Of Multiple Oral Doses Of PF-06743649
A Phase 1 Double Blind (3rd Party Open) Randomized, Placebo Controlled, Dose Escalation Study To Investigate The Safety,Tolerability, Pharmacokinetics And Pharmacodynamics Of Repeat Doses Of Pf-06743649 With Or Without Food In Healthy Adult Subjects
Status: Enrolling
Updated:  10/23/2014
New Haven Clinical Research Unit
537
mi
from 43215
New Haven, CT
A Study In Healthy People To Evaluate Safety, Toleration, Pharmacokinetics And Pharmacodynamics Of Multiple Oral Doses Of PF-06743649
A Phase 1 Double Blind (3rd Party Open) Randomized, Placebo Controlled, Dose Escalation Study To Investigate The Safety,Tolerability, Pharmacokinetics And Pharmacodynamics Of Repeat Doses Of Pf-06743649 With Or Without Food In Healthy Adult Subjects
Status: Enrolling
Updated: 10/23/2014
New Haven Clinical Research Unit
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
Safety and Pharmacokinetics Study of Redosing EXPAREL in Healthy Volunteers
An Open-Label Cohort Study to Evaluate the Safety and Pharmacokinetics of Redosing EXPAREL Via Local Subcutaneous Infiltration in Healthy Volunteers
Status: Enrolling
Updated:  10/27/2014
Medpace Clinical Pharmacology Unit
94
mi
from 43215
Cincinnati, OH
Safety and Pharmacokinetics Study of Redosing EXPAREL in Healthy Volunteers
An Open-Label Cohort Study to Evaluate the Safety and Pharmacokinetics of Redosing EXPAREL Via Local Subcutaneous Infiltration in Healthy Volunteers
Status: Enrolling
Updated: 10/27/2014
Medpace Clinical Pharmacology Unit
94
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Intravenous and Multiple Subcutaneous and Intravenous Doses of PF-06480605 in Healthy Subjects.
A Phase 1, Randomzied, Double-blind, Third-party Open Placebo-controlled, Dose Escalating Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Single Intravenous And Multiple Subcutaneous And Intravenous Doses Of Pf-06480605 In Healthy Subjects
Status: Enrolling
Updated:  11/7/2014
New Haven Clinical Research Unit
537
mi
from 43215
New Haven, CT
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Intravenous and Multiple Subcutaneous and Intravenous Doses of PF-06480605 in Healthy Subjects.
A Phase 1, Randomzied, Double-blind, Third-party Open Placebo-controlled, Dose Escalating Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Single Intravenous And Multiple Subcutaneous And Intravenous Doses Of Pf-06480605 In Healthy Subjects
Status: Enrolling
Updated: 11/7/2014
New Haven Clinical Research Unit
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
Evaluation of Plaque Fluid Fluoride Retention From Fluoride Toothpastes
Evaluation of Plaque Fluid Fluoride Retention From Fluoride Toothpastes
Status: Enrolling
Updated:  12/11/2014
Indiana University School of Dentistry
166
mi
from 43215
Indianapolis, IN
Evaluation of Plaque Fluid Fluoride Retention From Fluoride Toothpastes
Evaluation of Plaque Fluid Fluoride Retention From Fluoride Toothpastes
Status: Enrolling
Updated: 12/11/2014
Indiana University School of Dentistry
166
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
A Study to Demonstrate Bioequivalence Between a 12-mg Dose of an Oral Suspension Formulation of Perampanel and a 12-mg Tablet Formulation of Perampanel Under Fasted and Fed Conditions in Healthy Subjects
A Randomized, Open-Label, Crossover Study to Demonstrate Bioequivalence Between a 12-mg Dose of an Oral Suspension Formulation of Perampanel and a 12-mg Tablet Formulation of Perampanel Under Fasted and Fed Conditions in Healthy Subjects
Status: Enrolling
Updated:  12/15/2014
Clinical Research Facility
1144
mi
from 43215
San Antonio, TX
A Study to Demonstrate Bioequivalence Between a 12-mg Dose of an Oral Suspension Formulation of Perampanel and a 12-mg Tablet Formulation of Perampanel Under Fasted and Fed Conditions in Healthy Subjects
A Randomized, Open-Label, Crossover Study to Demonstrate Bioequivalence Between a 12-mg Dose of an Oral Suspension Formulation of Perampanel and a 12-mg Tablet Formulation of Perampanel Under Fasted and Fed Conditions in Healthy Subjects
Status: Enrolling
Updated: 12/15/2014
Clinical Research Facility
1144
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
A Single and Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics, and Target Engagement of BMS-986147 in Healthy Subjects
A Randomized, Double-Blinded, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics, and Target Engagement of BMS-986147 in Healthy Subjects
Status: Enrolling
Updated:  12/31/2014
Wcct Global, Llc
1967
mi
from 43215
Cypress, CA
A Single and Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics, and Target Engagement of BMS-986147 in Healthy Subjects
A Randomized, Double-Blinded, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics, and Target Engagement of BMS-986147 in Healthy Subjects
Status: Enrolling
Updated: 12/31/2014
Wcct Global, Llc
1967
mi
from 43215
Cypress, CA
Click here to add this to my saved trials
Validation of a Wearable Sensor for Stress Response in a Virtual Reality Environment
Validation of a Wearable Sensor for Stress Response in a Virtual Reality Environment
Status: Enrolling
Updated:  1/14/2015
Virtual Reality Medical Center
1951
mi
from 43215
San Diego, CA
Validation of a Wearable Sensor for Stress Response in a Virtual Reality Environment
Validation of a Wearable Sensor for Stress Response in a Virtual Reality Environment
Status: Enrolling
Updated: 1/14/2015
Virtual Reality Medical Center
1951
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
Brassica Intake and Isothiocyanate Absorption
Brassica Intake and Isothiocyanate Absorption: Intake Patterns May Have Implications for Cancer Prevention by Dietary Brassica Vegetables
Status: Enrolling
Updated:  1/20/2015
US Department of Agriculture Beltsville Human Nutrition Research Center
332
mi
from 43215
Beltsville, MD
Brassica Intake and Isothiocyanate Absorption
Brassica Intake and Isothiocyanate Absorption: Intake Patterns May Have Implications for Cancer Prevention by Dietary Brassica Vegetables
Status: Enrolling
Updated: 1/20/2015
US Department of Agriculture Beltsville Human Nutrition Research Center
332
mi
from 43215
Beltsville, MD
Click here to add this to my saved trials
Probiotics and Health-related Quality of Life in Individuals With Seasonal Allergies
Probiotics (Lactobacillus Gasseri KS-13, Bifidobacterium Bifidum G9-1, Bifidobacterium Longum MM-2) and Health-related Quality of Life in Individuals With Seasonal Allergies
Status: Enrolling
Updated:  1/28/2015
University of Florida
714
mi
from 43215
Gainesville, FL
Probiotics and Health-related Quality of Life in Individuals With Seasonal Allergies
Probiotics (Lactobacillus Gasseri KS-13, Bifidobacterium Bifidum G9-1, Bifidobacterium Longum MM-2) and Health-related Quality of Life in Individuals With Seasonal Allergies
Status: Enrolling
Updated: 1/28/2015
University of Florida
714
mi
from 43215
Gainesville, FL
Click here to add this to my saved trials
Vasopressin Effects on Human Social Communication
Phase 2 Study of Vasopressin Effects on Human Social Communication
Status: Enrolling
Updated:  1/29/2015
Maine Medical Center, McGeachey Hall, OP Psych
704
mi
from 43215
Portland, ME
Vasopressin Effects on Human Social Communication
Phase 2 Study of Vasopressin Effects on Human Social Communication
Status: Enrolling
Updated: 1/29/2015
Maine Medical Center, McGeachey Hall, OP Psych
704
mi
from 43215
Portland, ME
Click here to add this to my saved trials
A Study of LY2623091 in Healthy Participants
A Study to Determine the Effect of CYP3A Inhibition on the Pharmacokinetics of LY2623091 and the Effect of LY2623091 on the Pharmacokinetics of CYP3A Substrates in Healthy Subjects
Status: Enrolling
Updated:  1/29/2015
Covance Clinical Research Inc
749
mi
from 43215
Daytona Beach, FL
A Study of LY2623091 in Healthy Participants
A Study to Determine the Effect of CYP3A Inhibition on the Pharmacokinetics of LY2623091 and the Effect of LY2623091 on the Pharmacokinetics of CYP3A Substrates in Healthy Subjects
Status: Enrolling
Updated: 1/29/2015
Covance Clinical Research Inc
749
mi
from 43215
Daytona Beach, FL
Click here to add this to my saved trials
Effect Of Modafinil And Pioglitazone On The Pharmacokinetics Of Palbociclib (PD-0332991)
A Phase 1, Open-label, Fixed-sequence, 2-cohort, 2-period Study To Investigate The Effect Of Modafinil And Pioglitazone Given As Multiple Doses On Single Dose Pharmacokinetics Of Palbociclib (Pd-0332991) In Healthy Volunteers
Status: Enrolling
Updated:  2/3/2015
New Haven Clinical Research Unit
537
mi
from 43215
New Haven, CT
Effect Of Modafinil And Pioglitazone On The Pharmacokinetics Of Palbociclib (PD-0332991)
A Phase 1, Open-label, Fixed-sequence, 2-cohort, 2-period Study To Investigate The Effect Of Modafinil And Pioglitazone Given As Multiple Doses On Single Dose Pharmacokinetics Of Palbociclib (Pd-0332991) In Healthy Volunteers
Status: Enrolling
Updated: 2/3/2015
New Haven Clinical Research Unit
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
Effects of Tolvaptan in Healthy Adults
Variation in the Aquaretic Efficacy of Tolvaptan in Healthy Adults
Status: Enrolling
Updated:  2/26/2015
Clinical Research Unit Northwestern Memorial Hospital
274
mi
from 43215
Chicago, IL
Effects of Tolvaptan in Healthy Adults
Variation in the Aquaretic Efficacy of Tolvaptan in Healthy Adults
Status: Enrolling
Updated: 2/26/2015
Clinical Research Unit Northwestern Memorial Hospital
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
A Study To Observe Safety And Blood Concentrations Of PF-06649751 During And Following The Oral Administration Of Multiple Doses Of PF-06649751 In Healthy Adult Volunteers
A Phase 1, Double Blind, Sponsor Open, Randomized, Placebo Controlled, Dose Escalation, Parallel Group Study To Investigate The Safety, Tolerability And Pharmacokinetics Of Repeat Doses Of Pf-06649751 In Healthy Western And Japanese Subjects
Status: Enrolling
Updated:  3/4/2015
New Haven Clinical Research Unit
537
mi
from 43215
New Haven, CT
A Study To Observe Safety And Blood Concentrations Of PF-06649751 During And Following The Oral Administration Of Multiple Doses Of PF-06649751 In Healthy Adult Volunteers
A Phase 1, Double Blind, Sponsor Open, Randomized, Placebo Controlled, Dose Escalation, Parallel Group Study To Investigate The Safety, Tolerability And Pharmacokinetics Of Repeat Doses Of Pf-06649751 In Healthy Western And Japanese Subjects
Status: Enrolling
Updated: 3/4/2015
New Haven Clinical Research Unit
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
A Study of LY2801653 in Healthy Participants Who Are Not Able to Have Children
Relative Bioavailability and the Effect of Food on the Bioavailability of LY2801653 in Healthy Subjects
Status: Enrolling
Updated:  3/5/2015
Covance, Inc.
751
mi
from 43215
Daytona Beach, FL
A Study of LY2801653 in Healthy Participants Who Are Not Able to Have Children
Relative Bioavailability and the Effect of Food on the Bioavailability of LY2801653 in Healthy Subjects
Status: Enrolling
Updated: 3/5/2015
Covance, Inc.
751
mi
from 43215
Daytona Beach, FL
Click here to add this to my saved trials
A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira) In Healthy Subjects (REFLECTIONS B538-07))
Phase 1, Double Blind, Randomized, Parallel-group, 3-arm, Single-dose, Comparative Pharmacokinetic Study Of Pf-06410293 and Adalimumab Sourced From Us And Eu Administered To Healthy Male And Female Subjects
Status: Enrolling
Updated:  3/11/2015
Seaview Jacksonville, LLC
678
mi
from 43215
Jacksonville, FL
A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira) In Healthy Subjects (REFLECTIONS B538-07))
Phase 1, Double Blind, Randomized, Parallel-group, 3-arm, Single-dose, Comparative Pharmacokinetic Study Of Pf-06410293 and Adalimumab Sourced From Us And Eu Administered To Healthy Male And Female Subjects
Status: Enrolling
Updated: 3/11/2015
Seaview Jacksonville, LLC
678
mi
from 43215
Jacksonville, FL
Click here to add this to my saved trials
A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira) In Healthy Subjects (REFLECTIONS B538-07))
Phase 1, Double Blind, Randomized, Parallel-group, 3-arm, Single-dose, Comparative Pharmacokinetic Study Of Pf-06410293 and Adalimumab Sourced From Us And Eu Administered To Healthy Male And Female Subjects
Status: Enrolling
Updated:  3/11/2015
SeaView Reseach Screening Office
993
mi
from 43215
Miami, FL
A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira) In Healthy Subjects (REFLECTIONS B538-07))
Phase 1, Double Blind, Randomized, Parallel-group, 3-arm, Single-dose, Comparative Pharmacokinetic Study Of Pf-06410293 and Adalimumab Sourced From Us And Eu Administered To Healthy Male And Female Subjects
Status: Enrolling
Updated: 3/11/2015
SeaView Reseach Screening Office
993
mi
from 43215
Miami, FL
Click here to add this to my saved trials
A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira) In Healthy Subjects (REFLECTIONS B538-07))
Phase 1, Double Blind, Randomized, Parallel-group, 3-arm, Single-dose, Comparative Pharmacokinetic Study Of Pf-06410293 and Adalimumab Sourced From Us And Eu Administered To Healthy Male And Female Subjects
Status: Enrolling
Updated:  3/11/2015
SeaView Research Inc.
996
mi
from 43215
Miami, FL
A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira) In Healthy Subjects (REFLECTIONS B538-07))
Phase 1, Double Blind, Randomized, Parallel-group, 3-arm, Single-dose, Comparative Pharmacokinetic Study Of Pf-06410293 and Adalimumab Sourced From Us And Eu Administered To Healthy Male And Female Subjects
Status: Enrolling
Updated: 3/11/2015
SeaView Research Inc.
996
mi
from 43215
Miami, FL
Click here to add this to my saved trials
A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira) In Healthy Subjects (REFLECTIONS B538-07))
Phase 1, Double Blind, Randomized, Parallel-group, 3-arm, Single-dose, Comparative Pharmacokinetic Study Of Pf-06410293 and Adalimumab Sourced From Us And Eu Administered To Healthy Male And Female Subjects
Status: Enrolling
Updated:  3/11/2015
SeaView Research, Inc. (Screening Office)
993
mi
from 43215
Miami, FL
A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira) In Healthy Subjects (REFLECTIONS B538-07))
Phase 1, Double Blind, Randomized, Parallel-group, 3-arm, Single-dose, Comparative Pharmacokinetic Study Of Pf-06410293 and Adalimumab Sourced From Us And Eu Administered To Healthy Male And Female Subjects
Status: Enrolling
Updated: 3/11/2015
SeaView Research, Inc. (Screening Office)
993
mi
from 43215
Miami, FL
Click here to add this to my saved trials
A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira) In Healthy Subjects (REFLECTIONS B538-07))
Phase 1, Double Blind, Randomized, Parallel-group, 3-arm, Single-dose, Comparative Pharmacokinetic Study Of Pf-06410293 and Adalimumab Sourced From Us And Eu Administered To Healthy Male And Female Subjects
Status: Enrolling
Updated:  3/11/2015
Vince and Associates Clinical Research
338
mi
from 43215
Overland Park, KA
A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira) In Healthy Subjects (REFLECTIONS B538-07))
Phase 1, Double Blind, Randomized, Parallel-group, 3-arm, Single-dose, Comparative Pharmacokinetic Study Of Pf-06410293 and Adalimumab Sourced From Us And Eu Administered To Healthy Male And Female Subjects
Status: Enrolling
Updated: 3/11/2015
Vince and Associates Clinical Research
338
mi
from 43215
Overland Park, KA
Click here to add this to my saved trials
A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira) In Healthy Subjects (REFLECTIONS B538-07))
Phase 1, Double Blind, Randomized, Parallel-group, 3-arm, Single-dose, Comparative Pharmacokinetic Study Of Pf-06410293 and Adalimumab Sourced From Us And Eu Administered To Healthy Male And Female Subjects
Status: Enrolling
Updated:  3/11/2015
Vince and Associates Clinical Research
338
mi
from 43215
Overland Park, KA
A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira) In Healthy Subjects (REFLECTIONS B538-07))
Phase 1, Double Blind, Randomized, Parallel-group, 3-arm, Single-dose, Comparative Pharmacokinetic Study Of Pf-06410293 and Adalimumab Sourced From Us And Eu Administered To Healthy Male And Female Subjects
Status: Enrolling
Updated: 3/11/2015
Vince and Associates Clinical Research
338
mi
from 43215
Overland Park, KA
Click here to add this to my saved trials
A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira) In Healthy Subjects (REFLECTIONS B538-07))
Phase 1, Double Blind, Randomized, Parallel-group, 3-arm, Single-dose, Comparative Pharmacokinetic Study Of Pf-06410293 and Adalimumab Sourced From Us And Eu Administered To Healthy Male And Female Subjects
Status: Enrolling
Updated:  3/11/2015
Prism Research Inc.
617
mi
from 43215
Saint Paul, MN
A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira) In Healthy Subjects (REFLECTIONS B538-07))
Phase 1, Double Blind, Randomized, Parallel-group, 3-arm, Single-dose, Comparative Pharmacokinetic Study Of Pf-06410293 and Adalimumab Sourced From Us And Eu Administered To Healthy Male And Female Subjects
Status: Enrolling
Updated: 3/11/2015
Prism Research Inc.
617
mi
from 43215
Saint Paul, MN
Click here to add this to my saved trials
A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of PF-04958242 in Healthy Subjects
A Phase 1, Open-label, Fixed-sequence Study To Estimate The Effects Of Multiple-dose Administration Of Itraconazole On The Pharmacokinetics Of Pf 04958242 In Healthy Adult Subjects
Status: Enrolling
Updated:  3/12/2015
Pfizer New Haven Clinical Research Unit
537
mi
from 43215
New Haven, CT
A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of PF-04958242 in Healthy Subjects
A Phase 1, Open-label, Fixed-sequence Study To Estimate The Effects Of Multiple-dose Administration Of Itraconazole On The Pharmacokinetics Of Pf 04958242 In Healthy Adult Subjects
Status: Enrolling
Updated: 3/12/2015
Pfizer New Haven Clinical Research Unit
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
A Pilot Study To Investigate The Effect Of Concurrent Antacid Administration On The Bioavailability Of Six Experimental Formulations Of Palbociclib
A Phase 1, Open‑Label Fixed‑Sequence 2‑Period Crossover Study Of Palbociclib (pd‑0332991) In Healthy Volunteers To Estimate The Effect Of Antacid Treatment On The Bioavailability Of A 125 Mg Single Dose Of Six Experimental Formulations Of Palbociclib Relative To Palbociclib Administration Alone Under Fasted Conditions
Status: Enrolling
Updated:  4/13/2015
MRA Clinical Research - Phase 1
993
mi
from 43215
Miami, FL
A Pilot Study To Investigate The Effect Of Concurrent Antacid Administration On The Bioavailability Of Six Experimental Formulations Of Palbociclib
A Phase 1, Open‑Label Fixed‑Sequence 2‑Period Crossover Study Of Palbociclib (pd‑0332991) In Healthy Volunteers To Estimate The Effect Of Antacid Treatment On The Bioavailability Of A 125 Mg Single Dose Of Six Experimental Formulations Of Palbociclib Relative To Palbociclib Administration Alone Under Fasted Conditions
Status: Enrolling
Updated: 4/13/2015
MRA Clinical Research - Phase 1
993
mi
from 43215
Miami, FL
Click here to add this to my saved trials
A Pilot Study To Investigate The Effect Of Concurrent Antacid Administration On The Bioavailability Of Six Experimental Formulations Of Palbociclib
A Phase 1, Open‑Label Fixed‑Sequence 2‑Period Crossover Study Of Palbociclib (pd‑0332991) In Healthy Volunteers To Estimate The Effect Of Antacid Treatment On The Bioavailability Of A 125 Mg Single Dose Of Six Experimental Formulations Of Palbociclib Relative To Palbociclib Administration Alone Under Fasted Conditions
Status: Enrolling
Updated:  4/13/2015
MRA Clinical Research, LLC
997
mi
from 43215
South Miami, FL
A Pilot Study To Investigate The Effect Of Concurrent Antacid Administration On The Bioavailability Of Six Experimental Formulations Of Palbociclib
A Phase 1, Open‑Label Fixed‑Sequence 2‑Period Crossover Study Of Palbociclib (pd‑0332991) In Healthy Volunteers To Estimate The Effect Of Antacid Treatment On The Bioavailability Of A 125 Mg Single Dose Of Six Experimental Formulations Of Palbociclib Relative To Palbociclib Administration Alone Under Fasted Conditions
Status: Enrolling
Updated: 4/13/2015
MRA Clinical Research, LLC
997
mi
from 43215
South Miami, FL
Click here to add this to my saved trials
A Pilot Study To Investigate The Effect Of Concurrent Antacid Administration On The Bioavailability Of Six Experimental Formulations Of Palbociclib
A Phase 1, Open‑Label Fixed‑Sequence 2‑Period Crossover Study Of Palbociclib (pd‑0332991) In Healthy Volunteers To Estimate The Effect Of Antacid Treatment On The Bioavailability Of A 125 Mg Single Dose Of Six Experimental Formulations Of Palbociclib Relative To Palbociclib Administration Alone Under Fasted Conditions
Status: Enrolling
Updated:  4/13/2015
MRA Clinical Research, LLC
997
mi
from 43215
South Miami, FL
A Pilot Study To Investigate The Effect Of Concurrent Antacid Administration On The Bioavailability Of Six Experimental Formulations Of Palbociclib
A Phase 1, Open‑Label Fixed‑Sequence 2‑Period Crossover Study Of Palbociclib (pd‑0332991) In Healthy Volunteers To Estimate The Effect Of Antacid Treatment On The Bioavailability Of A 125 Mg Single Dose Of Six Experimental Formulations Of Palbociclib Relative To Palbociclib Administration Alone Under Fasted Conditions
Status: Enrolling
Updated: 4/13/2015
MRA Clinical Research, LLC
997
mi
from 43215
South Miami, FL
Click here to add this to my saved trials
A Study With an Open-Label Active Control to Evaluate the Potential of Nestorone® to Delay Cardiac Repolarization in Healthy Female Volunteers
A Double-Blind, Placebo-Controlled, Randomized, Crossover Design Study With an Open-Label Active Control to Evaluate the Potential of Nestorone® to Delay Cardiac Repolarization in Healthy Female Volunteers: A Thorough QT/QTc Study
Status: Enrolling
Updated:  4/16/2015
Harbor Hospital, 3001 South Hanover Street, 7th Floor
344
mi
from 43215
Baltimore, MD
A Study With an Open-Label Active Control to Evaluate the Potential of Nestorone® to Delay Cardiac Repolarization in Healthy Female Volunteers
A Double-Blind, Placebo-Controlled, Randomized, Crossover Design Study With an Open-Label Active Control to Evaluate the Potential of Nestorone® to Delay Cardiac Repolarization in Healthy Female Volunteers: A Thorough QT/QTc Study
Status: Enrolling
Updated: 4/16/2015
Harbor Hospital, 3001 South Hanover Street, 7th Floor
344
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Multiple Ascending Dose Safety Study of ShK-186 (Dalazatide) in Healthy Volunteers
A Double-Blind, Placebo-Controlled Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of ShK-186
Status: Enrolling
Updated:  5/13/2015
Pra International
mi
from 43215
Lenexa, KA
Multiple Ascending Dose Safety Study of ShK-186 (Dalazatide) in Healthy Volunteers
A Double-Blind, Placebo-Controlled Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of ShK-186
Status: Enrolling
Updated: 5/13/2015
Pra International
mi
from 43215
Lenexa, KA
Click here to add this to my saved trials
Temperature Evaluation by MRI Thermometry During Cervical Cooling
Temperature Evaluation by MRI Thermometry During Cervical Cooling
Status: Enrolling
Updated:  6/8/2015
University of Vermont Medical Center
591
mi
from 43215
Burlington, VT
Temperature Evaluation by MRI Thermometry During Cervical Cooling
Temperature Evaluation by MRI Thermometry During Cervical Cooling
Status: Enrolling
Updated: 6/8/2015
University of Vermont Medical Center
591
mi
from 43215
Burlington, VT
Click here to add this to my saved trials
Study to Evaluate Safety and Tolerability of Single Ascending Doses of Multiple Formulations of PF-06650833 in Healthy Subjects Under Fasted and Fed Conditions
A Phase 1, Randomized, Double Blind, Sponsor Open, Placebo Substitution, Crossover, Single Dose Escalation Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of Pf 06650833 Delivered In Multiple Formulations In Healthy Subjects Under Fasted And Fed Conditions
Status: Enrolling
Updated:  7/1/2015
New Haven Clinical Research Unit
537
mi
from 43215
New Haven, CT
Study to Evaluate Safety and Tolerability of Single Ascending Doses of Multiple Formulations of PF-06650833 in Healthy Subjects Under Fasted and Fed Conditions
A Phase 1, Randomized, Double Blind, Sponsor Open, Placebo Substitution, Crossover, Single Dose Escalation Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of Pf 06650833 Delivered In Multiple Formulations In Healthy Subjects Under Fasted And Fed Conditions
Status: Enrolling
Updated: 7/1/2015
New Haven Clinical Research Unit
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials